RRC
59
-4
EMC
54
-2
MCHP
45
-4
CCI
33
-5
ITW
37
-6
KHC
29
2
MU
56
-6
CSCO
58
-2
IBM
62
-3
PH
71
-3
LB
22
-7
ORLY
40
-4
LOW
46
-3
HRL
30
-5
VMC
53
-6
GD
57
-3
L
65
-4
AES
51
-4
LH
48
-2
CNP
55
-2
RRC
59
-4
EMC
54
-2
MCHP
45
-4
CCI
33
-5
ITW
37
-6
KHC
29
2
MU
56
-6
CSCO
58
-2
IBM
62
-3
PH
71
-3
LB
22
-7
ORLY
40
-4
LOW
46
-3
HRL
30
-5
VMC
53
-6
GD
57
-3
L
65
-4
AES
51
-4
LH
48
-2
CNP
55
-2
Financhill
Back

VictoryShares US SmCp High Div Vol Wtd ETF Vs. Nektar Therapeutics Industry Stock Comparison

Buy
53

CSB
VictoryShares US SmCp High Div Vol Wtd ETF

Last Price:
$59.80
Seasonality Move:
0.26%
Sell
42

NKTR
Nektar Therapeutics

Last Price:
$45.42
Seasonality Move:
11.58%
Buy
53
VictoryShares US SmCp High Div Vol Wtd ETF (CSB) is a Buy

Is VictoryShares US SmCp High Div Vol Wtd ETF a Buy, Sell or Hold?

  • The current VictoryShares US SmCp High Div Vol Wtd ETF [CSB] share price is $59.59. The Score for CSB is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
  • CSB is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
42
Nektar Therapeutics (NKTR) is a Sell

Is Nektar Therapeutics a Buy, Sell or Hold?

  • The current Nektar Therapeutics [NKTR] share price is $49.16. The Score for NKTR is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • NKTR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CSB Stock Price Chart

What is VictoryShares US SmCp High Div Vol Wtd ETF's stock price today?

  • The VictoryShares US SmCp High Div Vol Wtd ETF share price today is $59.59
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CSB is experiencing slight selling pressure.

NKTR Stock Price Chart

What is Nektar Therapeutics's stock price today?

  • The Nektar Therapeutics share price today is $49.16
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing slight buying pressure.

CSB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.56 Buy
Relative Strength Index (14 RSI): 58.66 Buy
Chaikin Money Flow: -4864 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (57.38 - 59.64) Buy
Bollinger Bands (100): (57.13 - 59.53) Buy

NKTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.43 Sell
Relative Strength Index (14 RSI): 38.92 Sell
Chaikin Money Flow: 341847 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

CSB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 59.52 Buy
20-day SMA: 58.7 Buy
50-day SMA: 58.13 Buy
200-day SMA: 56.96 Buy
8-day EMA: 59.56 Buy
20-day EMA: 58.99 Buy
50-day EMA: 57.38 Buy
200-day EMA: 36.48 Buy

NKTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 54.87 Sell
20-day SMA: 57.43 Sell
50-day SMA: 58.05 Sell
200-day SMA: 31.04 Buy
8-day EMA: 54.11 Sell
20-day EMA: 56.28 Sell
50-day EMA: 55.42 Sell
200-day EMA: 38.13 Buy

VictoryShares US SmCp High Div Vol Wtd ETF Earnings Growth & CSB Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Nektar Therapeutics Earnings Growth & NKTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and a decrease next year of $0.27 per share.

VictoryShares US SmCp High Div Vol Wtd ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nektar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):